UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000046449
Receipt number R000053002
Scientific Title Effects of alcohol on emotion.
Date of disclosure of the study information 2021/12/24
Last modified on 2022/12/26 20:21:00

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effects of alcohol on emotion.

Acronym

Effects of alcohol on emotion.

Scientific Title

Effects of alcohol on emotion.

Scientific Title:Acronym

Effects of alcohol on emotion.

Region

Japan


Condition

Condition

No

Classification by specialty

Not applicable Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To investigate effects of alcohol on emotion.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Brain waves

Key secondary outcomes

Body temperature
Breath alcohol concentration
Questionnaire


Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Food

Interventions/Control_1

1st:Drinking alcoholic beverages
2nd:Drinking non-alcoholic beverages

Interventions/Control_2

1st:Drinking non-alcoholic beverages
2nd:Drinking alcoholic beverages

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

29 years-old >=

Gender

Male and Female

Key inclusion criteria

(1) Healthy Japanese subjects 20 years old or more and less than 29 years old who have written informed consent
(2) Individuals who can take alcoholic beverages
(3) Individuals who have given the written informed consent

Key exclusion criteria

(1) Individuals who plan to hazardous work such as driving a vehicle, or operating machineries on the day of study
(2) Individuals who cannot take alcoholic beverages, have no experience to take alcoholic beverages, are hypersensitive to alcohol, are pregnant, plan to become pregnant, are lactation, or have alcohol allergy symptoms
(3) Individuals who are judged by the principal investigator to be inappropriate for this study as subjects based on the results of the background investigation
(4) Individuals who have a chronic disease and use medicines continuously, or have a history of serious diseases (e.g., diabetes, liver disease, kidney disease, heart disease, thyroid gland disease, adrenal gland disease, and/or metabolic disorder)
(5) Individuals who have a history of digestive disease affecting digestion and absorption, or have a history of digestive surgery
(6) Individuals who cannot stop intake of alcoholic beverages or alcohol-containing foods on the previous day and the day of study
(7) Individuals who regularly take medicines that can affect mental status
(8) Individuals who have a history or current condition of drug or alcohol dependence
(9) Individuals who have a history of mental illness or epilepsy
(10) Individuals with drug and/or food allergy

Target sample size

20


Research contact person

Name of lead principal investigator

1st name Takehiko
Middle name
Last name Shimura

Organization

Dentsu ScienceJam Inc.

Division name

President

Zip code

107-0052

Address

102 TRES Akasaka, 4-2-28 Akasaka, Minato-ku, Tokyo, Japan

TEL

03-6435-5316

Email

takehiko.shimura@jam.dentsu.co.jp


Public contact

Name of contact person

1st name Takehiko
Middle name
Last name Shimura

Organization

Dentsu ScienceJam Inc.

Division name

President

Zip code

107-0052

Address

102 TRES Akasaka, 4-2-28 Akasaka, Minato-ku, Tokyo, Japan

TEL

03-6435-5316

Homepage URL


Email

takehiko.shimura@jam.dentsu.co.jp


Sponsor or person

Institute

Dentsu ScienceJam Inc.

Institute

Department

Personal name



Funding Source

Organization

Kirin Holdings Company, Limited

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ethical Review Committee of Dentsu ScienceJam Inc.

Address

102 TRES Akasaka, 4-2-28 Akasaka, Minato-ku, Tokyo, Japan

Tel

03-6435-5316

Email

info@dentsusciencejam.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2021 Year 12 Month 24 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2021 Year 11 Month 09 Day

Date of IRB

2021 Year 11 Month 09 Day

Anticipated trial start date

2022 Year 04 Month 22 Day

Last follow-up date

2022 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2021 Year 12 Month 23 Day

Last modified on

2022 Year 12 Month 26 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000053002